DYADIC INTERNATIONAL INC Prepaid Expense and Other Assets, Current
DYADIC INTERNATIONAL INC (DYAI) had Prepaid Expense and Other Assets, Current of $418.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $418.94K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $174.24K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $219.07K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $339.94K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $418.94K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $174.24K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $219.07K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $339.94K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $84.98K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $210.87K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $303.07K 10-K · filed 2026-03-25 |
| 2024-09-30 | $374.21K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $126.72K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $242.13K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $327.77K 10-K · filed 2025-03-26 |
| 2023-09-30 | $484.19K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $136.15K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $284.60K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $392.24K 10-K · filed 2024-03-28 |
| 2022-09-30 | $448.21K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $104.83K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $244.17M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $375.83K 10-K · filed 2023-03-29 |
| 2021-09-30 | $569.97K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $100.89K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $216.19K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $280.56K 10-K · filed 2022-03-29 |
| 2020-09-30 | $419.50K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $599.51K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $288.50K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $278.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $336.87K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $112.14K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $166.94K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $172.00K 10-K · filed 2020-03-30 |
| 2017-12-31 | $154.61K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |